{"related:BkTXw94-KOcJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5":[{"title":"Systemic therapy for metastatic renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMra1601333","authors":["TK Choueiri","TK Choueiri RJ Motzer"],"year":2017,"numCitations":424,"pdf":"https://medicinainternaelsalvador.com/wp-content/uploads/2017/02/Systemic-Therapy-for-Metastatic-Renal-Cell.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16656632348319106054&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:BkTXw94-KOcJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16656632348319106054&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc","p":1,"exp":1596898395668},{"title":"Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5455807/","authors":["TK Choueiri","TK Choueiri S Halabi","TK Choueiri S Halabi BL Sanford","TK Choueiri S Halabi BL Sanford O Hahn…"],"year":2017,"numCitations":386,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5455807/","citationUrl":"http://scholar.google.com/scholar?cites=5181895643400921433&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:WWEOAKLK6UcJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5181895643400921433&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"ncbi.nlm.nih.gov"},{"title":"Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial","url":"https://www.sciencedirect.com/science/article/pii/S1470204516301073","authors":["TK Choueiri","TK Choueiri B Escudier","TK Choueiri B Escudier T Powles","TK Choueiri B Escudier T Powles NM Tannir…"],"year":2016,"numCitations":565,"pdf":"https://helda.helsinki.fi/bitstream/handle/10138/224076/Cabozantinib_versus_everolimus.pdf?sequence=1&isAllowed=y","citationUrl":"http://scholar.google.com/scholar?cites=16074541589004785383&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:55bfm2g-FN8J:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16074541589004785383&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Elsevier"},{"title":"Evolving systemic treatment landscape for patients with advanced renal cell carcinoma","url":"https://ascopubs.org/doi/abs/10.1200/JCO.2018.79.0253","authors":["RR McKay","RR McKay D Bossé","RR McKay D Bossé TK Choueiri"],"year":2018,"numCitations":21,"pdf":"/scholar?output=instlink&q=info:2Z7YsNAweUoJ:scholar.google.com/&hl=en&as_sdt=0,5&scioq=systemic+therapy&scillfp=16454098984877026151&oi=lle","citationUrl":"http://scholar.google.com/scholar?cites=5366374103866973913&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:2Z7YsNAweUoJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5366374103866973913&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"ascopubs.org"},{"title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","authors":["RJ Motzer","RJ Motzer NM Tannir","RJ Motzer NM Tannir DF McDermott…"],"year":2018,"numCitations":1247,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","citationUrl":"http://scholar.google.com/scholar?cites=13898631485117911629&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:TVKDlrLb4cAJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13898631485117911629&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"},{"title":"Systemic therapy of metastatic renal cell carcinoma: Review of the current literature","url":"https://journals.sagepub.com/doi/abs/10.1177/0391560318802166","authors":["I Zerdes","I Zerdes M Tolia","I Zerdes M Tolia N Tsoukalas","I Zerdes M Tolia N Tsoukalas M Mitsis…"],"year":2019,"numCitations":3,"citationUrl":"http://scholar.google.com/scholar?cites=10308692035828559963&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:W7B17snUD48J:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10308692035828559963&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"journals.sagepub.com"},{"title":"Optimizing treatment approaches in advanced renal cancer","url":"https://www.cancernetwork.com/renal-cell-carcinoma/optimizing-treatment-approaches-advanced-renal-cancer","authors":["JC Osorio","JC Osorio RJ Motzer","JC Osorio RJ Motzer MH Voss"],"year":2017,"numCitations":3,"pdf":"https://www.cancernetwork.com/renal-cell-carcinoma/optimizing-treatment-approaches-advanced-renal-cancer","citationUrl":"http://scholar.google.com/scholar?cites=16504607547931507078&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:hjmwox4lDOUJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16504607547931507078&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"cancernetwork.com"},{"title":"Cabozantinib versus everolimus in advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1510016","authors":["TK Choueiri","TK Choueiri B Escudier","TK Choueiri B Escudier T Powles…"],"year":2015,"numCitations":765,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1510016","citationUrl":"http://scholar.google.com/scholar?cites=15416788208830885159&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:J63LvDFv89UJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15416788208830885159&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"},{"title":"Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1816047","authors":["RJ Motzer","RJ Motzer K Penkov","RJ Motzer K Penkov J Haanen","RJ Motzer K Penkov J Haanen B Rini…"],"year":2019,"numCitations":502,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1816047","citationUrl":"http://scholar.google.com/scholar?cites=1882792696390332365&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:za8LXvsFIRoJ:scholar.google.com/&scioq=systemic+therapy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1882792696390332365&hl=en&as_sdt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"}]}